XXI Wealth’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$534K Sell
18,708
-7,426
-28% -$198K 0.21% 118
2026
Q2
$629K Sell
26,134
-4,685
-15% -$123K 0.29% 88
2026
Q1
$865K Buy
30,819
+5,626
+22% +$150K 0.49% 53
2025
Q4
$627K Buy
+25,193
New +$635K 0.38% 71

Other funds holding PFE

XXI Wealth's PFE Position: Q3 2026 in Review

XXI Wealth reduced its Pfizer (PFE) stake by 28% in Q3 2026, selling an estimated $198K and leaving 18,708 shares worth $534K. The position accounts for 0.21% of the portfolio, ranked #118.

XXI Wealth first reported a position in PFE in Q4 2025 and has held it in 4 quarters since. The position peaked at $865K in Q1 2026. 2,877 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • XXI Wealth held 18,708 shares of Pfizer worth $534K as of Q3 2026.
  • XXI Wealth sold 7,426 Pfizer shares in Q3 2026, an estimated $198K.
  • Pfizer made up 0.21% of XXI Wealth's portfolio in Q3 2026, its #118 holding.
  • XXI Wealth first reported a position in Pfizer in Q4 2025 and has held it in 4 quarters since.
  • XXI Wealth's Pfizer position peaked at $865K in Q1 2026.
  • 2,877 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on XXI Wealth's 13F filing for Q3 2026, filed 22 Oct 2026.